Chapter PDF
Literatur
Abella BS, Becker LB (2002) Ischemia-reperfusion and acute apoptotic cell death. In: Vincent JL (ed) 2002 Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 3–11
Adams HA, Baumann G, Gänsslen A et al. und die IAG Schock (2001) Die Definitionen der Schockformen. Intensivmed 38: 541–553
AHA — ECC (2000) Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care — a consensus on science. Circulation 102(Suppl 8): I1–I384
Ahnefeld FW, Barth J, Dick W et al. (1994) Akuttherapie anaphylaktoider Reaktionen. Anästhesist 43: 211–222
Alpert JS, Becker RC (1993) Cardiogenic shock: elements of etiology, diagnosis, and therapy. Clin Cardiol 16(3): 182–190
American Thoracic Society, European Society of Intensive Care Medicine, Societé de Reanimation Langue Francaise (1999) International consensus conferences in intensive care medicine. Ventilator-associated lung injury in ARDS. Intensive Care Med 25: 1444–1452
Andersen HR, Nielsen TT, Rasmussen K et al. (2003) A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349: 733–742
Annane D, Cavaillon JM (2003) Corticosteroids in sepsis: from bench to bedside? Shock 20: 197–207
Annane D, Sébille V, Charpentier et al. (2002) Effect of a treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288: 862–871
Antoniucci D, Valenti R, Santoro GM et al. (1998) Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: In-hospital and long-term survival. J Am Coll Cardiol 31: 294–300
Antoniucci D, Valenti R, Migliorini A et al. (2002) Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation. Am J Cardiol 90(4): 353–357
Antoniucci D, Valenti R, Migliorini A et al. (2003) Comparison of impact of emergency percutaneous revascularization on outcome of patients >or =75 to those <75 years of age with acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 91(12): 1458–1461
Artigas A, Bernard GR, Carlet J et al. and the Consensus Committee (1998) The American-European Consensus Conference of ARDS, Part 2. Am J Respir Crit Care Med 157: 1332–1347
Asfar P, Pierrot M, Veal V et al. (2003) Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Crit Care Med 31: 215–220
Austin SM, Barooah B, Kim CS (1984) Reversible acute cardiac injury during cefoxitin-induced anaphylaxis in a patient with normal coronary arteries. Am J Med 77: 729–732
Bahrami S, Redl H, Schlag G (1998) Der Darm als Ursache von Sepsis und Multiorganversagen. Wien Klin Wochenschr 110(Suppl 1): 2–10
Ballal RS, Sanyal RS, Nanda NC, Mahan EF III (1993) Usefulness of transesophageal echocardiography in the diagnosis of ventricular septal rupture secondary to acute myocardial infarction. Am J Cardiol 71: 367–370
Barron HV, Every NR, Parsons LS et al. (2001) The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction. Am Heart J 141: 933–939
Baue AE, Faist E, Fry DE (2000) Multiple organ failure — pathophysiology, prevention and therapy. Springer, Berlin Heidelberg New York
Behringer W, Kittler H, Sterz F et al. (1998) Cumulative epinephrine dose during cardiopulmonary resuscitation and neurologic outcome. Ann Intern Med 129: 450–456. Editorial (Cummins RO, Hazinski MF) 129:501-502
Beilman GJ, Groehler KE, Lazaron V, Ortner JP (1999) Near-infrared spectroscopy measurement of regional tissue oxyhemoglobin saturation during hemorrhagic shock. Shock 12: 196–200
Beishuizen A, Thijs LG (2003) Endotoxin and the hypothalamo-pituitaryadrenal (HPA) axis. J Endotoxin Res 9: 3–24
Bernard SA, Buist M (2003) Induced hypothermia in critical care medicine: A review. Crit Care Med 31: 2041–2051
Bernard GR, Vincent JL, Laterne PF et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699–709
Bengur AR, Meliones JN (1998) Cardiogenic shock. New Horiz 6(2): 139–149
Bernard SA, Gray TW, Buist MD et al. (2002) Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 346: 557–5634
Bertolini G, Iapichino G, Radrizzani D (2003) Early enteral immunonutrition in patients with severe sepsis — Results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med 29: 834–840
Birnbaum Y, Fishbein MC, Blanche C, Siegel RJ (2002) Ventricular septal rupture after acute myocardial infarction. N Engl J Med 347: 1426–1432
Blumberg N, Heal JM (1998) Blood transfusion immunomodulation — the silent epidemic. Arch Pathol Lab Med 122: 117–119
Bodmann KF, Vogel F (2001) Antimikrobielle Therapie der Sepsis — Empfehlungen einer Arbeitsgruppe der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. Chemotherapie J 10: 43–55
Boekstegers P, Weidenhöfer S, Kapsner T, Werdan K (1994) Skeletal muscle partial pressure of oxygen in patients with sepsis. Crit Care Med 22: 640–650
Böhm D (2002) Anwendung pharmakokinetischer Prinzipien bei kritisch Kranken. In: Böhm D, Werdan K (Hrsg) Themenheft: Rationale Arzneimitteltherapie bei kritisch Kranken. Intensiv Notfallbehandl 27: 156–164
Böhm D, Werdan K (2002) Editorial. Themenheft: Rationale Arzneimitteltherapie bei kritisch Kranken. Intensiv Notfallbehandl 27: 153–155
Böker KHW, Manns MP (1998) Akutes Leberversagen. Internist 39: 442–452
Boldt J (2003) Verursacht Hydroxethylstärke (HES) ein Nierenversagen? Intensiv News 7: 17–19
Bond RF (1993) Peripheral macro-and microcirculation. In: Schlag G, Redl H (eds) Pathophysiology of shock, sepsis and organ failure. Springer, Berlin Heidelberg New York, pp 893–907
Bonnefoy E, Lapostolle F, Leizorovicz A et al. (2002) Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 360: 825–829
Bonz AW, Lengenfelder B, Strotmann J et al. (2002) Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial). J Am Coll Cardiol 40: 662–668
Booth BH, Patterson R (1970) Electrocardiographic changes in human anaphylaxis. JAMA 211: 627
Bowers TR, O’Neill WW, Grines C et al. (1998) Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med 338: 933–940
Brealey D, Brand M, Hargreaves I (2002) Association between mitochondrial dysfunction and severity and outcome of septic shock. lancet 360: 219–223
Briegel J (2003) Septische Enzephalopathie — häufig verkannt und unterschätzt. Anaesthesist 52: 293
Briegel J, Forst H, Haller M et al. (1999) Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27: 723–732
Brodie BR, Stuckey TD, Hansen C et al. (1999) Intra-aortic ballon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction; Am J Cardiol 84: 18–23
Bruch C, Comber M, Schmermund A et al. (2003) Diagnostic usefulness and impact on management of transesophageal echocardiography in surgical intensive care units. Am J Cardiol 91: 510–513
Bur A, Bayegan K, Holzer M et al. (2002) Intra-aortic balloon counterpulsation in the emergency department: a 7-year review and analysis of predictors of survival. Resuscitation 53: 259–264
Burchardi H, Briegel J, Eckart J et al. (2000) Expertenforum: Hämodynamisch aktive Substanzen in der Intensivmedizin. Anästhesiol Intensivmed 41: 560–631
Califf RM, Bengtson JR (1994) Cardiogenic shock. N Engl J Med 330: 1724–1730
Calvo FE, Figueras J, Cortadellas J, Soler JS (1997) Severe mitral regurgitation complicating acute myocardial infarction. Clinical and angiographic differences between patients with and without papillary muscle rupture. Eur Heart J 18: 1606–1610
Carlson RW, Schaeffer RC, Puri VK et al. (1981) Hypovolemia and permeability pulmonary edema associated with anaphylaxis. Crit Care Med 9: 883
Chan AW, Chew DP, Bhatt DL et al. (2002) Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 89: 132–136
Cheifetz IM, Craig DM, Kern FH et al. (1996) Nitric oxide improves transpulmonary vascular mechanics but does not change intrinsic right ventricular contractility in an acute respiratory distress syndrome model with permissive hypercapnia. Crit Care Med 24: 1554–1561
Choi PT-L, Yip G, Quinonez LG, Cook DJ (1999) Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 27: 200–210
Christ F, Lackner CK (2004) Präklinische Versorgung des Patienten im Schock. Internist 45: 267–276
Ciurana CLF, Hack CE (2002) Molecular Mechanisms of complement Activation during Ischemia and Reperfusion. In: Vincent JL (ed) 2002 Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 39–49
Claussen MS, Landercasper J, Cogbill TH (1992) Acute adrenal insufficiency presenting as shock after trauma and surgery: three cases and review of the literature. J Trauma 32: 94–100
Cobas Meyer M, Depka M von (2003) Neue gerinnungsphysiologische Erkenntnisse in der schweren Sepsis: Sind diese in der Diagnostik nutzbar? In: Huhle G (Hrsg) Themenheft: Sepsis und Gerinnung. Intensiv Notfallbehandl 28: 37–43
Cohen J (2000) The detection and interpretation of endotoxaemia (2000) Intensive Care Med 26:S52-S56
Cohen M, Urban P, Christenson JT et al. (2003) Intra-aortic ballon counterpulsation in US and Non-US-Centers: Results of Benchmark-Registry; European Heart Journal 24: 1763–1770
Cohen TJ, Goldner BG, Maccaro PC et al. (1993) A comparison of active compression-decompression cardiopulmonary resuscitation with standard cardiopulmonary resuscitation for cardiac arrests occurring in the hospital. N Engl J Med 329: 1918–1921
Cole L, Bellomo R, Journois D et al. (2001) High-volume haemofiltration in human septic shock. Intensive Care Med 27: 978–986
Cooper DJ, Walley KR, Wiggs BR, Russell JA (1990) Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: a prospective, controlled clinical study. Ann Intern Med 112: 492–498
Corwin HL, Gettinger A, Pearl RG (2002) Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 288: 2827–2835
Cotter G, Moshkovitz Y, Kaluski E et al. (2003a) The role of cardiac power and systemic vascular resistance in the pathopyhsiology and diagnosis of patients with acute congestive heart failure. Eur J Heart Fail 5: 443–451
Cotter G, Williams SG, Vered Z, Tan LB (2003b) Role of cardiac power in heart failure. Current Opinion Cardiology 18: 215–222
Cotter G, Kaluski E, Milo O et al. (2003c) LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study. Eur Heart J 24: 1287–1295
Cox FF, Morshuis WJ, Plokker HWT et al. (1996) Early mortality after surgical repair of postinfarction ventricular septal rupture: importance of rupture location. Ann Thorac Surg 61: 1752–1758
Cuffe MS, Califf RM, Adams KF et al. (2002) For the Outcome of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure — a randomized controlled trial. JAMA 287: 1541–1547
Cummings RG, Califf R, Jones RN et al. (1997) Correlates of survival in patients with postinfarction ventricular septal defect. Ann Thorac Surg 63: 1508–1509
Czock D, Keller F (2002) SIRS und Sepsis — akutes Nierenversagen — Nierenersatzverfahren und Dosisanpassung von Medikamenten. In: Böhm D, Werdan K (Hrsg) Themenheft: Rationale Arzneimitteltherapie bei kritisch Kranken. Intensiv Notfallbehandl 27: 172–183
De Backer D (2003) Lactic acidosis. Intensive Care Med 29: 699–702
De Backer D, Creteur J, Preiser JC et al. (2002) Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 166: 98–104
Dellinger RP (2003) Cardiovascular management of septic shock. Crit Care Med 31: 946–955
Dellinger RP, Carlet JM, Masur H et al. (2004) For the Surviving Sepsis Campaign Management Guidelines Committee: Surviving Sepsis Campaign Guidelines for management of severe sepsis and septic shock. Crit Care Med 32: 858–873; Intensive Care Med 30: 536-555
Dempfle CE (2003) Veränderungen der Hämostase in der Sepsis: Ursachen oder Folgen? In: Huhle G (Hrsg) Themenheft: Sepsis und Gerinnung Intensiv Notfallbehandl 28: 26–36
De Vega JMA, Diaz J, Serrano E, Carbonelli LF (2002) Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 30: 1782–1786
DeWerra I, Jaccard C, Betz Corradin S et al. (1997) Cytokines, nitrite/nitrate, soluble tumor factor receptors, and procalcitonin concentations: Comparison in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 25: 607–613
Dhainaut JF, Dall’Ava J, Mira JP (1993) Coronary hemodynamics and myocardial metabolism in sepsis and septic shock. In: Schlag G, Redl H (eds) Pathophysiology of shock, sepsis and organ failure. Springer, Berlin Heidelberg New York, pp 882–892
Dieterich HJ (2001) Kristalloide versus Kolloide — A never ending story? Anaesthesist 50: 432–435
Donnino M, Nguyen B, Rivers E (2002) Hemodynamic comparison of early and late phase severe sepsis and septic shock. Chest 122:5S
Dörges V, Wenzel V (2001) Ventilation zur kardiopulmonalen Reanimation. Intensivmed 38: 576–589
Dorian P, Cass D, Schwartz B (2002) Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 346: 884–890
Douzinas EE, Pitaridis MT, Louris G et al. (2000) Prevention of infection in multiple trauma patients by high-dose intravenous immunoglobulins. Crit Care Med 28: 8–15
Dünser MW, Mayr AJ, Ulmer H et al. (2001) The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and post-cardiotomy shock: a retrospective analysis. Anesth Analg 93: 7–13
Dünser MW, Mayr AJ, Ulmer H et al. (2003) Arginine Vasopressin in advanced vasodilatory shock. Circulation 107: 2313–2319
Dzavik V, Sleeper LA, Cocke TP et al. (2003) Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J 24: 828–837
Eckardt KU (2003) Das Ende der Blutkonserven? Intensiv-News 7: 24–25
Eggers V, Schilling A, Kox WJ, Spies C (2003) Septische Enzephalopathie — Differentialdiagnose und therapeutische Einflußmöglichkeiten. Anaesthesist 52: 294–303
Eisenberg MS, Mengert TJ (2001) Cardiac resuscitation. N Engl J Med 344: 1304–1313
Eisenberg PR, Jaffe AS, Schuster DP (1984) Clinical evaluation compared to pulmonary artery catheterization in the hemodynamic assessment of critically ill patients. Crit Care Med 12: 549–553
Elsakka N, Galley HF, Webster NR (2001) Mitochondrial antioxidant activity and disease processes. In: Vincent JL (ed) Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 278–283
Emmenegger V, Frey U, Reimers A et al. (2001) Hyperferritinemia as indicator of intravenous immunoglobulin treatment in reactive macrophage acitvation syndromes. Am J Hematology 68: 4–10
Engelmann L (2000a) Update-Thema: Akutes Lungenversagen — ARDS. Intensiv Notfallbehandl 25: 87–96
Engelmann L (2000b) Das Open-Lung-Konzept. Internist 41: 985–994
Fernandes CJ Jr, Akamine N, De Marco FVC (2001) Red blood cell transfusion does not increase oxygen consumption in criticaly ill septic patients. Crit Care Med 5: 362–367
Ferrari M, Figulla HR (2005) Mechanische Herz-Kreislaufunterstützung in der Kardiologie. Dtsch Med Wochenschr (im Druck)
Ferrari M, Wittmann G, Neumann S et al. (1998) Die perkutan implantierbare Herz-Lungen-Maschine erweitert die therapeutischen und diagnostischen Möglichkeiten bei therapierefraktärem Kreislaufstillstand — Fallpräsentation und Übersicht. Intensivmed 35: 56–61
Figueras J, Cortadellas J, Domingo E, Soler-Soler J (2001) Survival following self-limited left ventricular free wall rupture dring myocardial infarction. Management differences between patients with or without pseudoaneurysm formation. Int J Cardiol 79: 103–111. Letter to the Editor: Beranek JT (2002) Pathogenesis of postinfarction free wall rupture. 84:91-92
Fink MP (2003) Ethyl pyruvate: a novel anti-inflammatory agent. In: Vincent JL (ed) Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 604–614
Finney SJ, Evans TW, Burke-Gaffney A (2002) Cell adhesion molecules and leucocyte trafficking in sepsis. In: Vincent JL (ed) Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 23–38
Fletcher SN, Kennedy DD, Ghosh IR et al. (2003) Hinds: persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 31: 1012–1016
Flieger RRF, Werdan K (2004) Pulmonalarterienkatheter-Monitoring bei kritisch Kranken — Eine Momentaufnahme 2004. Intensiv-News 8: 9–13
Follath F, Cleland JGF, Just H (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360: 196–202
Formica M, Olivieri C, Livigni S (2003) Hemodynamic response to coupled plasmafi ltration-adsorption in human septic shock. Intensive Care Med 29: 703–708
Freeman BD, Parrillo JE, Natanson C (2001) Septic shock and multiple organ failure. In: Parrillo JE, Dellinger RP (eds) Critical care medicine principles of diagnosis and management in the adult, 2nd edn. Mosby, St. Louis, MO, pp 437–452
Gawaz M, Fateh-Moghadam S, Pilz G et al. (1995) Severity of multiple organ failure (MOF) but not of sepsis correlates with irreversible platelet degranulation. Infection 23: 16–23
Gellerich FN, Trumbeckaite S, Hertel K et al. (1999) Impaired energy metabolism in hearts of septic baboons: diminished activities of complex I and complex II of the mitochondrial respiratory chain. Shock 11: 336–341
Ginz HF, Gottschall V, Schwarzkopf G, Walter K (1998) Exzessive Gewebespeicherung von Kolloiden im retikuloendothelialen System. Anaesthesist 47: 330–334
Giri S, Mitchel J, Azar RR et al. (2002) Results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 89: 126–131
Godin PJ, Buchman TG (1996) Uncoupling of biological oscillators: A complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 24: 1107–1116
Goldberg RJ, Samad NA, Yarzebski J et al. (1999) Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 340: 1162–1168
Graf J, Graf C, Janssens U (2003) Nutzen intensivmedizinischer Scoring Systeme zur Beurteilung der Ergebnisqualität, Prognoseabschätzung und Kostenanalyse internistischer Intensivpatienten. Intensiv Notfallbehandl 28: 158–164
Granger CB, Mahaffey K, Weaver WD et al. (2003) Pexelizumab an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction. Circulation 108: 1184–1190
Green R, Scott LK, Minagar A, Conrad S (2004) Sepsis associated encephalopathy (SAE): a review. Frontiers Bioscience 9: 1637–1641
Gregg W, Stone E, Ohman M et al. (2003) Contemporary utilization and outcomes of intra-aortic ballon counterpulsation in acute myocardial infarction. J Am Coll Cardiol 41: 1940–1945
Groeneveld ABJ (2001) Hypovolemic shock. In: Parrillo JE, Dellinger RP (eds) Critical care medicine — principles of diagnosis and management in the adult, 2nd edn. Mosby, St. Louis, MO, pp 465–500
Groner W, Winkelman JW, Harris AG et al. (1999) Orthogonal polarization spectral imaging: a new method for study of the microcirculation. Nature Medicine 5: 1209–1213
Group THaCaS (2002) Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 346: 549
Gueugniaud PY, Mols P, Goldstein P et al. for the European Epinephrine Study Group (1998) A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. N Engl J Med 339: 1595–601. 340:1763-1765 (Correspondence 1999)
Guyton K, Bond R, Romeo C et al. (1999) Endotoxin-induced cross-tolerance to Gram-positive sepsis. J Endotoxin Res 5: 119–126
Hallstrom A, Cobb L, Johnson E, Copass M (2000) Cardiopulmonary resuscitation by chest compression alone or with mouth-to-mouth ventilation. N Engl J Med 342: 1546–1553
Hallström S, Koidl B, Müller U et al. (1993) Cardiodepressant factors. In: Schlag G, Redl H (eds) Pathophysiology of shock, sepsis and organ failure. Springer, Berlin Heidelberg New York, pp 200–214
Hamberger B, Fredholm BB, Farnebo LO (1980) Anaphylaxis and plasma catecholamines. Life Sci 26: 1465–1471
Hanashiro PK, Weil MH (1967) Anaphylactic shock in man: report of two cases with detailed hemodynamic and metabolic studies. Arch Intern Med 119: 129–140
Hamm CW (2004) Herausgegeben vom Vorstand der Deutschen Gesellschaft für Kardiologie — Herz-und Kreislaufforschung. Bearbeitet im Auftrag der Kommission für Klinische Kardiologie Leitlinien: Akutes Koronarsyndrom (ACS) Teil 1: ACS ohne persistierende ST-Hebung; Teil 2: Akutes Koronarsyndrom mit ST-Hebung (Myokardinfarkt). Z Kardiol 93: 72–90
Hasdai D, Topol EJ, Califf RM et al. (2000a) Cardiogenic shock complicating acute coronary syndromes. Lancet 356: 749–756
Hasdai D, Califf RM, Thompson TD et al. (2000b) Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol 35: 136–143
Hasdai D, Harrington RA, Hochman JS et al. (2000c) Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. J Am Coll Cardiol 36: 685–692
Haupt MT (2001) Anaphylaxis and anaphylactic Shock. In: Parrillo JE, Dellinger RP (eds) Critical care medicine — principles of diagnosis and management in the adult, 2nd edn. Mosby, St. Louis, MO, pp 513-526
Hausmann H, Potapov EV, Koster A et al. (2002) Prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new score. Circulation 106(Suppl I): I203–I206
Hayes MA, Timmins AC, Yau EHS (1994) Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330: 1717–1722
Hebert P, Wells G, Blajchman MA et al. (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340: 409–417
Heinroth KM, Kuhn C, Stache N et al. (1999) Eingeschränkte Herzfrequenzvariabilität bei Patienten mit septischem und nicht-septischem Multiorgan-Dysfunktions-Syndrom. Intensivmed 36: 436–445
Held AC, Cole PL, Lipton B et al. (1988) Rupture of the interventricular septum complicating acute myocardial infarction: a multicenter analysis of clinical findings and outcome. Am Heart J 116: 1330–1336
Hermann HB, Pieske B, Schwarzmüller E et al. (1999) Hemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: An open study. Lancet 353: 1321–1323
Herridge MS, Cheung AM, Tansey CM et al. for the Canadian Critical Care Trials Group (2003) One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 348: 683–693
Heyland DK, Samis A (2003) Does immunonutrition in patients with sepsis do more harm than good? Intensive Care Med 29: 669–671
Hochman JS, Sleeper LA, Webb JG et al. for the SHOCK Investigators (1999) Early revascularization in acute myocardial infarctions complicated by cardiogenic shock. N Engl J Med 341: 625–634
Hochman JS, Buller CE, Sleeper LA et al. (2000) Cardiogenic shock complicating acute myocardial infarction-etiologies, management and outcome: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 36: 1063–1070
Hochman JS, Talley JD, Webb JC et al. (1997) Ventricular septal rupture causing cardiogenic shock: clinical profile, timing and outcome. Circulation 96:I-749
Hoffmann B, Welte T (2002) Der akute Myokardinfarkt — ein unterschätzter und oft unerkannter Mortalitätsfaktor bei septischen Patienten? Intensivmed 39677–681
Hoffmann JN, Hartl W, Deppisch R et al. (1996) Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med 22: 1360–1367
Hoffmann JN, Werdan K, Hartl WH et al. (1999) Hemofiltrate from patients with severe sepsis and depressed left ventricular contractility contains cardiotoxic compounds. Shock 12/3: 174–180
Hollenberg SM (2001) Cardiogenic shock. Crit Care Clin 17(2): 391–410
Hollenberg SM (2003) Cardiogenic shock: overview. Intensivmed 40: 269–275
Hollenberg SM, Kavinsky CJ, Parrillo JE (1999) Cardiogenic shock. Ann Intern Med 131(1): 47–59
Holtz J (2000) Physiologische Wirkprinzipien. In: Burchardi H, Briegel J, Eckart J et al. (Hrsg) Expertenforum: Hämodynamisch aktive Substanzen in der Intensivmedizin. Anästhesiol Intensivmed 41: 562–568
Hotchkiss RS, Swanson PE, Freeman BD et al. (1999) Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27: 1230–1251
Hudson LD, Lee CM (2003) Neuromuscular sequelae of critical illness. N Engl J Med 348: 745–747
Huhle G (2003) Editorial. Themenheft: Sepsis und Gerinnung. Intensiv Notfallbehandl 28: 1–3
Hund E (2001) Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J Neurol 248: 929–934
Hund E, Abel R (2002) Spinaler Schock. Intensiv Notfallbehandl 27: 131–136
Ince C (2002) The microcirculation unveiled. Am J Resp Crit Caare Med 166: 1–4
Intravenous Immunoglobulin Study Group (1992) Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection. N Engl J Med 327: 234–240
Jacobs AK, French JK, Col J et al. for the SHOCK Investigators (2000) Cardiogenic shock with non-ST-segment elevation myocardial in-farction: a report from the SHOCK Trial Registry. J Am Coll Cardiol 36: 1091–1096
Jacobs AK Leopold JA, Bates E et al. (2003) Cardiogenic shock caused by right ventricular infarction. J Am Coll Cardiol 41: 1273–1279
Jakob SM, Takala J (2000) Splanchnic hemodynamics in critical illness. current Opinion in Critical Care 6: 123–129
Jakob SM, Tenhunen JJ, Heino A et al. (2002) Splanchnic vasoregulation during mesenteric ischemia and reperfusion in pigs. Shock 18: 142–147
Janssens (2001) Monitoring des herzkranken Intensivpatienten. Intensivmed 38: 232–250
Janssens U, Graf C, Graf J, Hanrath P (2002) Mortality Probability Model (MPM II0-72) bei Patienten einer kardiologischen Intensivstation. Intensivmed 39: 26–37
Janssens U, Graf J (2004) Was ist »Schock«? Internist 45: 258–266
Kato S, Morimoto S-I, Hiramitsu S et al. (1999) Use of percutaneous cardiopulmonary support of patients with fulminant myocarditis and cardiogenic shock for improving prognosis. Am J Cardiol 83: 623–625
Kellum JA (2003) Hemoadsorption therapy for sepsis syndromes. Crit Care Med 31: 323–324
Kierdorf H (2001) Akutes Nierenversagen. Intensiv-und Notfallbehandlung, Themenheft 1 und 2/2001
Kilger E, Weis F, Briegel J et al. (2003) Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 31: 1068–1074
Killen DA, Piehler JM, Borkon AM et al. (1997) Early repair of postinfarction ventricular septal rupture. Ann Thorac Surg 63: 138–142
Kivikko M, Lehtonen L, Coloucci WS et al. (2003) Sustained hemodynamic effects of intravenous levosimendan. Circulation 107: 81–86
Khot UM, Novaro GM, Popovic ZB et al. (2003) Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med 348: 1756–1763
Klinzing S, Simon M, Reinhart K et al. (2003) High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 31: 2646–2650
Knaus WA, Draper EA, Wagner DP, Zimmermann JE (1985) APACHE II: A severity of disease classification system. Crit Care Med 13: 818–829
König G, Guggenberger M, Bommersbach B (1996) 40jähriger Patient ohne Vorerkrankung mit akuter Schocksymptomatik und schwerer Verbrauchskoagulopathie. Internist 37: 74–77
Konstantinides S, Hasenfuß G (2004) Akutes Cor Pulmonale bei Lungenembolie — Entscheidender prognostischer Faktor und kritischer Parameter für die Auswahl der therapeutischen Strategie. Internist 45: 1155–1162
Kontoyannis DA et al. (1999) Mechanical ventilation in conjunction with the intra-aortic ballon pump improves the outcome of patients in profound cardiogenic shock. Intensive Care Med 25: 835–838
Köster A, Chew DP, Kuebler W et al. (2003) Effects of tirofiban on hemostatic activation and inflammatory response during cardiopulmonary bypass. Am J Cardiol 91: 346–347
Kovack PJ, Rasak MA, Bates ER et al. (1997) Thrombolysis plus aortic counterpulsation: Improved survival in patients who present to community hospitals with cardiogenic shock. J Am Coll Cardiol 29: 1454–1458
Kreimeier U, Prückner S (1998) Volumentherapie bei Hypovolämie und Schock. Notfall Rettungsmed 1: 119–129
Kress HG, Scheidewig C, Schmitt H et al. (1999) Reduced incidence of post-operative infections following intravenous application of an IgA-and IgM-enriched immunoglobulin preparation in anergic patients undergoing cardiac surgery. Crit Care Med 27: 1281–1287, 1387-1388
Krishnagopalan S, Kumar A, Parrillo JE, Kumar A (2002) Myocardial dysfunction in the patient with sepsis. Current Opinion Crit Care 8: 376–388
Kuhn C, Müller-Werdan U, Schmitt DV et al. (2000) Improved outcome of APACHE II score-defined escalating systemic inflammatory response syndrome in patients post cardiac surgery in 1996 compared to 1988-1990. Eur J Cardiothorac Surg 17: 30–37
Kujath P, Bouchard R, Heinze I et al. (2003) Aktiviertes Protein C, Antithrombin, Heparin und Gewebethromboplastininhibitor: Neue Algorithmen für die Therapie der Sepsis? In: Huhle G (Hrsg) Themenheft: Sepsis und Gerinnung. Intensiv Notfallbehandl 28: 44–54
Kumar A, Parrillo JE ( 2001) Shock: classification, pathophysiology and approach to management. In: Parrillo JE, Dellinger RP (eds) Critical Care Medicine — Principles of diagnosis and management in the adult. Mosby, St. Louis MO, 2nd edn., pp 371–420
Laggner AN (2004) Der Schockpatient auf der Notaufnahme und der Intensivstation. Internist 45: 277–283
Lamy M, Nys M, Deby-Dupont G (2001) Reactive nitrogen and oxygen species: role and evidence of their production in humans. In: Vincent JL (ed) 2001 Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 284–301
Lefevre N, Delaunay L, Hingot JL, Bonnet F (1996) Bilateral massive adrenal haemorrhage complicating anaphylactic shock: a case report. Intenvive Care Med 22: 447–449
Lehmann D, Radke J, Werdan K (2003) Beatmung beim Herzkranken. In: Werdan K, Trappe HJ, Zerkowski HR (Hrsg) Das Herzbuch — Praktische Herz-Kreislauf-Medizin. Urban & Fischer, München Jena, S. 309–326
Lemery R, Smith HC, Fiuliani ER, Gersh BJ (1992) Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention. Am J Cardiol 70: 147–151
Lesage A et al. (2004) Complicated acute myocardial infarction requiring mechanical ventilation in the intensive care unit: prognostic factors of clinical outcome in series of 157 patients. Crit Care Med 32(1): 100–105
Levy M, Fink MP, Marshall JC et al. for the International Sepsis Definitions Conference (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definition Conference. Intensive Care Med 29: 530–538 und Crit Care Med 31:1250-1256
Li L, Jacinto R, Yoza B, McCall CE (2003) Distinct post-receptor alterations generate gene-and signal-selective adaptation and cross-adaptation of TLR4 and TLR2 in human leukocytes. J Endotoxin Res 9: 39
Liaudet L, Soriano FG, Szabó C (2001) Poly(ADP-Ribose) synthetase as a novel therapeutic target for circulatory shock. In: Vincent JL (ed) 2002 Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 78–89
Lincoff AM, Kereiakes DJ, Mascelli MA et al. (2001) Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization. Circulation 104(2): 163–167
Lindenfeld JA (1998) Safety and effectiveness of inhaled nitric oxide and tirofiban for acute coronary syndromes — a report from the Cardiovascular and Renal Advisory Panel of the Food and Drug Administration. Circulation 98: 1829–1830
Lindholm MG, Aldershvile J, Sundgreen C et al. (2003) Effect of early revascularisation in cardiogenic shock complicating acute myocardial infarction. A single center experience. Eur J Heart Failure 5: 73–79
Lopez A, Lorente JA, Steingrub J et al. (2004) Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32: 21–30
Loppnow H (2001) Zytokine: Klassifikation, Rezeptoren, Wirkungsmechanismen. Internist 42: 13–27
Lowe PR, Galley HF, Abdel-Fattah A et al. (2003) Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients. Crit Care Med 31: 34–38
Lu PP, Shee JJ, Chen HM et al. (1999) Spinal nitric oxide participates in the control of the blood pressure during graded hemorrhage in the conscious rat. Shock 12: 222–226
Mailman D, Self A, Henry M (1999) Time-and surgery-dependent effects of lipopolysaccharide on gut, cardiovascular and nitric oxide functions. Shock 12: 208–214
Maisch B, Christ M (2004) Extrakardiale Ursachen der Rechtsherzinsuffizienz. Internist 45: 1136–1146
Martin J, Siegenthaler MP, Krause M et al. (2003) Mechanische Kreislaufunterstützung bei akuter und chronischer Herzinsuffizienz — eine Standortbestimmung unter besonderer Berücksichtigung der Entwicklung in Deutschland. Zentralbl Chir 128: 796–803
McDonough KH, Giaimo ME, Miller HI (1995) Effects of endotoxin on the guinea pig heart response to ischemia reperfusion injury. Shock 4: 139–142
Mehta L, Pascual MT, Soroko S (2002) Diuretics, mortality and nonrecovery of renal function in acute renal failure. JAMA 288: 2547–2553
Meier-Hellman A, Burgard G (2004) Neue Therapieansätze bei der prähospitalen und hospitalen Schockbehandlung — Hyperton-onkotische Lösungen und Vasopressin. Internist 45: 305–314
Melzer C, Gliech A von, Baumann G, Theres H (2001) Severe aortic stenosis and reduced ejection fraction: intensive care treatment. Intensive Care Med 27: 617
Menon V, White H, LeJemtel T et al. for the SHOCK Investigators (2000a) The clinical profi le of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. J Am Coll Cardiol 36: 1071–1076
Menon V, Webb JG, Hillis LD et al. for the SHOCK Investigators (2000b) Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. J Am Coll Cardiol 36: 1110–1116
Menon V, Slater JN, White HD et al. (2000c) Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK Trial Registry. Am J Med 108: 374–380
Meyer J, Merx W, Dörr R et al. (1982) Successful treatment of acute myocardial infarction shock by combined percutaneous transluminal coronary recanalization and percutaneous coronary angioplasty. Am Heart J 103: 132–134
Michie HR, Manogue KR, Spriggs DR et al. (1988) Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318: 1481–1486
Moerer O, Rossi L de, Roissant R, Burchardi H (2005) Sepsis — Epidemiologie und ökonomische Aspekte. In: Werdan K, Schuster HP, Müller-Werdan U (Hrsg) Intensivtherapie bei Sepsis und MODS, 4. Aufl. Springer, Berlin Heidelberg New York
Mohr E, Englisch L, Roth A et al. (1997) Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis. Intensive Care Med 23: 1144–1149
Moiseyev VS, Pöder P, Andrejevs N et al. on behalf of RUSSLAN Study Investigators (2002) Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure de to an acute myocardial infarction. Eur Heart J 23: 1422–1432
Moldawer LL (1999) Organ apoptosis in the septic patient: A potential therapeutic target? Crit Care Med 27: 1381–1382
Moscucci M, Bates ER (1995) Cardiogenic shock. Cardiol Clin 13: 391–406
Moss J, Fahmy NR, Sunder N, Beaven MA (1981) Hormonal and hemodynamic profile of an anaphylactic reaction in man. Circulation 63: 210–213
Motoyama T, Okamoto K, Kukita I et al. (2003) Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome: Crit Care Med 31: 1048–1052
Mullan BA, McCloskey BV (2002) Antioxidants and endothelial function. In: Vincent JL (ed) 2002 Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 113–120
Mueller HS, Chatterjee K, Davis KB et al. (1998) ACC expert consensus document. Present use of bedside right heart catheterisation in patients with cardiac disease. J Am Coll Cardiol 32: 840–864
Müller-Werdan U (2003) Septischer Schock und systemisches Entzündungsreaktions-Syndrom. Dtsch Med Wochenschr 128: 2367–2378
Müller-Werdan U, Werdan K (2000) Anaphylaxie und Allergie — Empfehlungen für die Notfalltherapie. Internist 41: 363–373
Müller-Werdan U, Werdan K (1999) Septic cardiomyopathy. Curr Opin Crit Care 5: 415–420
Müller-Werdan U, Werdan K (2003) Endorganschäden bei Entzündung und Sepsis. Internist 44: 864–871
Müller-Werdan U, Werdan K (2005) Septischer Kreislaufschock und septische Kardiomyopathie. In: Werdan K, Schuster HP, Müller-Werdan U (Hrsg) Intensivtherapie bei Sepsis und MODS, 4. Aufl. Springer, Berlin Heidelberg New York
Müller-Werdan U, Reithmann C, Werdan K (1996) Cytokines and the heart — molecular mechanisms of septic cardiomyopathy. Landes, Austin USA
Müller-Werdan U, Werdan K, Schuster HP (1999) Monitoring von kritisch Kranken mit Sepsis, Multiorgandysfunktionssyndrom und Herz-Kreislauf-Erkrankungen. Intensiv Notfallbeh 24: 10–24
Müller-Werdan U, Buerke M, Werdan K (2003) Fortschritte in der Therapie der Sepsis. Internist 44(12): 1531–1540
Nolan JP, Morley PT, Hoek TL, Hickey RW (2003) Therapeutic hypothermia after cardiac arrest. An advisory statement by the Advancement Life support Task Force of the International Liaison committee on Resuscitation. Resuscitation 57: 231–235
O’Brien A, Clapp L, Singer M (2002) Terlipressin for norepinephrine-resistant septic shock. Lancet 359: 1209–1210
Pacht ER, DeMichele SJ, Nelson JL et al. (2003) Enteral nutrition with eicosapentaenoic acid,-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Crit Care Med 31: 491–500
Papadopoulos MC, Davies DC, Moss RF (2000) Pathophysiology of septic encephalopathy: a review. Crit Care Med 28: 3019–3024
Parkar N, Taylor RW (2001) Adrenal insufficiency in the critically ill patient. In: Parrillo JE, Dellinger RP (eds) Critical care medicine — principles of diagnosis and management in the adult, 2nd edn. Mosby, St. Louis MO, pp 1225–1234
Patel BM, Chittock DR, Russell JA, Walley KR (2002) Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96: 576–582
Pfisterer M (2003) Right ventricular involvement in myocardial infarction and cardiogenic shock. Lancet 362: 392–394
Plaisance P, Lurie KG, Vicaut E et al. (1999) A comparison of standard cardiopulmonary resucitation and active compression-decompression resuscitation for out-of-hospital cardiac arrest. N Engl J Med 341: 569–575
Priori SG, Bossaert LL, Chamberlain DA et al. (2004) ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe. Eur Heart J 25: 437–445
Prondzinsky R, Werdan K, Buerke M (2004) Kardiogener Schock: Pathomechanismen, klinischer Verlauf, therapeutische Ansätze und Perspektiven. Internist 45: 284–295
Prondzinsky R, Knüfer A, Loppnow H et al. (2005) Surgical trauma affects the proinflammatory status post cardiac surgery to a higher degree than cardiopulmonary bypass. J Thoracic Cardiovasc Surgery (in press)
Pulmonary Artery Consensus Conference Participants (1997) Pulmonary artery consensus conference: Consensus statement. Crit Care Med 25: 910–925
Rao RH, Vagnucci AH, Amico JH (1989) Bilateral massive adrenal hemorrhage: early recognition and treatment. Ann Intern Med 110: 227–235
Raper RF, Fisher MMD (1988) Profound reversible myocardial depression after anaphylaxis. Lancet I: 386–388
Raper R, Sibbald WJ, Driedger AA, Gerow K (1989) Relative myocardial depression in normotensive sepsis. J Crit Care 4: 9–18
Raper RF, Sibbald WJ (1988) The effects of coronary artery disease on cardiac function in nonhypotensive sepsis. Chest 94: 507–511
Rauchhaus M, Müller-Werdan U (2001) Zytokine bei Herzerkrankungen. Internist 42: 75–84
Read RC, Wyllie DH (2001) Toll receptors and sepsis. Curr Opin Crit Care 7: 371–375
Redl G, Germann P, Plattner H, Hammerle A (1993) Right ventricular function in early septic shock states. Intensive Care Med 19: 3–7
Redling F, Neumann I, Zerkowski H-R (1998) Herzverletzungen. Intensiv Notfallbeh 23: 85–95
Reinhart K, Meier-Hellmann A, Beale R et al. (2004) Open randomized phase II trial of an extracorporeal endotoxin absorber in suspected gram-negative sepsis. Crit Care Med 32: 1662–1668
Reithmann C, Hallström S, Pilz G et al. (1993) Desensitization of rat cardiomyocyte adenyl cyclase stimulation by plasma of noradrenalinetreated patients with septic shock. Circ Shock 41: 48–59
Riess H (1998) Hämostasestörungen im Umfeld von Sepsis und SIRS. Internist 39: 479–484
Rinne T, Zwissler B (2004) Intraoperatives anästhesiologisches Management bei Patienten mit pulmonaler Hypertonie. Intensiv Notfallbehandl 29: 4–13
Rivers, E., Nguyen, B., Havstad et al. for the Early Goal-Directed Therapy Collaborative Group (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368–1377 (Editorial: Evans TW. Hemodynamic and metabolic therapy in critically ill patients. 345:1417-1418)
Ruß M, Seige M, Werdan K (2005) Allgemeine Intensivtherapie. In: Paumgartner G (Hrsg) Therapie innerer Krankheiten, 11. Aufl. Springer, Berlin Heidelberg New York (im Druck)
Ryan TJ (1999) Early revascularization in cardiogenic shock — a positive view of a negative trial. N Engl J Med 341: 687–688
Sablotzki A, Dehne MG, Prondzinsky R et al. (2000) Management von Notfallsituationen im Krankenhaus. Intensiv Notfallbehandl 25: 152–160
SAFE Study Investigators (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350: 2247–2256 (Editorial: Cook D (2004) Is Albumin Safe? 350:2294-2296 )
Samtleben W, Bengsch S, Boos KS et al. (1998) HELP apheresis in the treatment of sepsis. Artif Organs 22: 43–46
Sanborn TA, Sleeper LA, Bates ER et al. (2000) Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 36(Suppl A): 1123–1129
Schlag G, Redl H (eds) (1993) Pathophysiology of shock, sepsis and organfailure. Springer, Berlin Heidelberg New York
Schmidt H, Müller-Werdan U (2003) Warum sollte der Intensivmediziner der autonomen Dysfunktion seiner Patienten Beachtung schenken? Intensiv Notfallbehandl 28: 137–146
Schmidt W, Nottrott M, Desel H (1998) Lebensbedrohliche akute Intoxikationen durch kardio-und vasotoxisch wirkende Medikamente und Drogen. Intensiv Notfallbeh 23: 27–49
Schmidt H, Werdan K, Müller-Werdan U (2001) Autonomic function in the ICU patient. Curr Opinion Crit Care 7: 314–322
Scholz KH, Figulla HR, Schröder T et al. (1995) Pulmonary and left ventricular decompression by artificial pulmonary valve incompetence during percutaneous cardiopulmonary bypass support in cardiac arrest. Circulation 91: 2664–2668
Schuster HP, Schuster FP, Ritschel P et al. (1997) The ability of the simplified acute physiology score (SAPS II) to predict outcome in coronary care patients. Intens Care Med 23: 381–384
Schwertz H, Müller-Werdan U, Prondzinsky R et al. (2004) Katecholamine im kardiogenen Schock: hilfreich, nutzlos oder gefährlich? Dt Med Wochenschr 129: 1925–1930
Seige M, Werdan K, Prondzinsky R (2001) Beatmung bei Herzkranken. Intensivmed 38: 299–313
Seyfarth M, Schömig A (2004) Die rechtsventrikuläre Beteiligung beim akuten Myokardinfarkt. Internist 45: 1117–1124
Shapiro MJ (2001) Traumatic shock: nonsurgical management. In: Parrillo JE, Dellinger RP (eds) Critical care medicine — principles of diagnosis and management in the adult, 2nd edn. Mosby, St. Louis MO, pp 501–512
Shapiro NI, Wolfe RE, Moore RB et al. (1996) Mortality in emergency department sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med 31: 670–675
Shehata N, Kouroukis C, Kelton JG (2002) A review of randomized controlled trials using therapeutic apheresis. Transfus Med Rev 16: 200–229
Silver MA, Horton DP, Ghali JK, Elkayam U (2002) Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. J Am Coll Cardiol 39: 798–803
Silverman HJ, Penaranda R, Orens JB, Lee NH (1993) Impaired β-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: association with myocardial hyporesponsiveness to catecholamines. Crit Care Med 21: 31–39
Silverman HJ, Van Hook C, Haponik EF (1984) Hemodynamic changes in human anaphylaxis. Am J Med 77: 341–343
Simon TL, Alverson DC, AuBuchon J et al. (1998) Practice parameter for the use of red blood cell transfusions — developed by the red blood cell administration practice guidelines development task force fo the College of American Pathologists. Arch Pathol Lab Med 122: 130–138
Slater J, Brown RJ, Antonelli TA et al. for the SHOCK Investigators (2000) Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. J Am Coll Cardiol 36: 1117–1122
Song W, Furman BL, Parratt JR (1994) Attenuation by dexamethasone of endotoxin protection against ischaemia-induced ventricular arrhythmias. Br J Pharmacol 113: 1083–1084
Spies C, Haude V, Fitzner R et al. (1998) Serum cardiac troponin T as a prognostic marker in early sepsis. Chest 113: 1055–1063
Stacpoole PW, Wright EC, Baumgartner TG et al. (1992) A controlled trial of dichloroacetate for treatment of lactic acidosis in adults. N Engl J Med 327: 1564–1569
Stallmach A, Zeitz M (1998) Der Darm als immunologisches Organ. Wien Klin Wochenschr 110: 72–78
Stegmayr BG (2001) Apheresis as therapy for patients with severe sepsis and multiorgan dysfunction syndrome. Therapeutic Apheresis 5: 123–127
Stegmayr BG, Banga R, Berggren L et al. (2003) Plasma exchange as rescue therapy in multiple organ failure ncluding acute renal failure. Crit Care Med 31: 1730–1736
Stomel RJ, Rasak M, Bates ER (1994) Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital. Chest 105: 997–1002
Suchner U (2002) Enterale Immunonutrition: wann, für wen, welche Zukunftsperspektiven gibt es? Aktuel Ernaehr Med 27: 205–215
Suffredini AF, Fromm RE, Parker MM et al. (1989) The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321: 280–287
Sullivan TJ (1982) Cardiac disorders in penicillin-induced anaphylaxis. JAMA 248: 2161–2162
Sun Q, Dimopoulos G, Nguyen DN et al. (2003) Low-dose vasopressin in the treatment of septic shock in sheep. Am J Respir Crit Care Med 168: 481–486
Szabó C, Liaudet L (2002) Myocardial ischemia-reperfusion injury: role of the peroxynitrite-poly(ADP-ribose) polymerase pathway. In: Vincent JL (ed) 2002 Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 165–176
Taniguchi T, Koido y, Aiboshi J et al. (1999) Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 27: 1262–1264
Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine (1999) Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med 27: 639–660
Tcheng JE, Jackman JD, Nelson CL et al. (1992) Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction. Ann Intern Med 117: 18–24
Thackray S, Easthaugh J, Freemantle N, Cleland JGF (2002) The effectivenes and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure — a meta-regression analysis. Eur Heart Fail 4: 515–529
Thiele H, Lauer L, Hambrecht R et al. (2001) Reversal of cardiogenic shock by percutaneuos left atrial to femoral artrial bypass-systems. Circulation 104: 2917–2922
Thiele H, Lauer B, Hambrecht R et al. (2003) Short-and long-term hemodynamic effects of intra-aortic balloon support in ventricular septal defect complicating acute myocardial infarction. Am J Cardiol 92: 450–454
Thiemermann C (1995) Inhibition of nitric oxide synthase activity in circulatory shock: friend or foe? In: Fink MP, Payen D (eds) Role of nitric oxide in sepsis and ARDS (update in intensive care and emergency medicine 24). Springer, Berlin Heidelberg New York, pp 201–216
Thiemermann C (2000a) Globale und regionale Zirkulationsstörungen bei Sepsis. In: Burchardi H, Briegel J, Eckart J et al. (Hrsg) Expertenforum: Hämodynamisch aktive Substanzen in der Intensivmedizin. Anästhesiol Intensivmed 41: 585–592
Thiemermann C (2000b) NOS-Inhibitoren. In: Burchardi H, Briegel J, Eckart J et al. (Hrsg) Expertenforum: Hämodynamisch aktive Substanzen in der Intensivmedizin. Anästhesiol Intensivmed 41: 614–615
Thompson CR, Buler CE, Sleeper LA et al. for the SHOCK Investigators (2000) Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. J Am Coll Cardiol 36: 1104–1109
Tsegai E, Schütze B, Gläser F et al. (2004) Nephritis epidemica auf einer interdisziplinären Notaufnahme — Fallsammlung im Rahmen einer Endemie-Erfassung der Ostalbregion und Literaturübersicht. Intensiv Notfallbehandl 29: 3
Tsuneyoshi I, Yamada H, Kakihana Y et al. (2001) Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 29: 487–493
Tulleken JE, Fijen JW, Zijlstra JG (2001) Inhibition of 38 mitogen activated protein kinase: a novel strategy in sepsis? In: Vincent JL (ed) 2001 Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 90–99
Van den Berghe G, Wouters P, Weekers F et al. (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345: 1359–1367 (Editorial: Evans TW. Hemodynamic and metabolic therapy in critically ill patients. 345: 1417-1418)
Van den Berghe G, Wouters PJ, Bouillon R et al. (2003) Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31: 359–366
Vincent JL, Moreno R, Takala J et al. on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction. Intensive Care Med 22:707–710
Visvanathan K, Zabriskie JB (2000) The role of bacterial superantigens in sepsis and treatment implications. Curr Opin Crit Care 6: 312–316
Walther A, Böttiger BW (2004) Anaphylaktoide Reaktionen in der Prähospitalphase. Internist 45: 296–304
Wang P, Hauptman JG, Chaudry IH (1990) Hemorrhage produces depression in microvascular blood flow which persists despite fluid resuscitation. Circ Shock 32: 307–318
Weil MH, Nakagawa Y, Tang W et al. (1999) Sublingual capnometry: a new noninvasive measurement for diagnosis and quantitation of severity of circulatory shock. Crit Care Med 27: 1225–1229
Wenzel V, Krismer AC, Arntz HR et al. (2004) A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 350: 105–113
Werdan K (2000) Septische Kardiomyopathie. In: Burchardi H, Briegel J, Eckart J et al. (Hrsg) Expertenforum: Hämodynamisch aktive Substanzen in der Intensivmedizin. Anästhesiol Intensivmed 41: 594–599
Werdan K (2001a) Mechanische und elektrische Therapie kardialer Arrhythmien. In: Van Aken H, Reinhart K, Zimpfer M (Hrsg) Intensivmedizin. Thieme, Stuttgart New York, 176–188
Werdan K (2001b) Assessment of IVIG for prophylaxis and therapy of sepsis. Curr Opin Crit Care 7: 354–361
Werdan K, Boekstegers P, Müller U et al. (1991) Akute septische Kardiomyopathie: Bestandteil des Multiorganversagens in der Sepsis? Med Klin 86: 526–534
Werdan K, Schuster HP, Müller-Werdan U (Hrsg) (2005) Intensivtherapie bei Sepsis und MODS, 4. Aufl. Springer, Berlin Heidelberg New York
Witthaut R, Busch C, Fraunberger P et al. (2003) Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 29: 1696–1702
Yao Z, Auchampach JA, Pieper GM, Gross GJ (1993) Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue in the dog. Cardiovasc Res 27: 832–838
Yocum MW, Butterfield JH, Klein JS et al. (1999) Epidemiology of anaphylaxis in Olmsted county: a population — based study. J Allergy Clin Immunol 104: 452–456
Zahn R, Fraiture B, Siegler KE et al. (2003) Effectiveness of the glycoprotein IIb/IIIa antagonist abciximab during percutaneous coronary interventions (PCI) in clinical practice at a single high-volume center. Z Kardiol 92: 438–444
Zauner C, Genod A, Kramer L et al. (2000) Metabolic encephalopathy in critically ill patients suffering from septic or nonseptic multiple organ failure. Crit Care Med 28: 1310–1315
Zehender M, Kasper W, Kauder E et al. (1993) Right ventricuar infarction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med 328: 981–988
Zell R, Geck P, Werdan K, Boekstegers P (1997) TNF-a and IL-1a inhibit both pyruvate dehydrogenase activity and mitochondrial function in cardiomyocytes: evidence for primary impairment of mitochondrial function. Mol Cell Biochem 177: 61–67
Zeymer U, Tebbe U, Weber M et al. (2003) Prospective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK Trial. J Invasive Cardiol 15: 385–389
Zeymer U, Vogt A, Zahn R for the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (2004) Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI) — Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). Eur Heart J 25: 322–328
Zonghai H, Han G, Renbao X (2002) Study on glucocorticoid receptors during intestinal ischemia shock and septic shock. Circ Res 23: 27–36
Zotz RJ, Dohmen G, Genth S, Erbel R, Meyer J (1993) Diagnosis of papillary muscle rupture after acute myocardial infarction by transthoracic and transesophageal echocardiography. Clin Cardiol 16: 665–670
Zweier JL, Wang P, Samouilov A, Kuppusami P (1995) Enzyme-independent formation of nitric oxide in biological tissues. Nature Med 1: 804–809; letter to the editor: 1103
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Müller-Werdan, U. et al. (2006). Schock. In: Erdmann, E. (eds) Klinische Kardiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29425-2_6
Download citation
DOI: https://doi.org/10.1007/3-540-29425-2_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23742-6
Online ISBN: 978-3-540-29425-2
eBook Packages: Medicine (German Language)